Lumito AB is a Swedish company that specializes in the medical research and development of imaging technology for use in digital pathology. It has developed a development and business plan for the development of an instrument for digital pathology that improves the quality of tissue sample mapping.
2010
1
Last FY Revenue $10K
Last FY EBITDA -$2.7M
$12.4M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Lumito achieved revenue of $10K and an EBITDA of -$2.7M.
Lumito expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Lumito valuation multiples based on analyst estimatesNTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|
Revenue | XXX | $10K | XXX | XXX | XXX |
Gross Profit | XXX | $0.4M | XXX | XXX | XXX |
Gross Margin | XXX | 4192% | XXX | XXX | XXX |
EBITDA | XXX | -$2.7M | XXX | XXX | XXX |
EBITDA Margin | XXX | -26127% | XXX | XXX | XXX |
EBIT | XXX | -$4.0M | XXX | XXX | XXX |
EBIT Margin | XXX | -38885% | XXX | XXX | XXX |
Net Profit | XXX | -$4.3M | XXX | XXX | XXX |
Net Margin | XXX | -42194% | XXX | XXX | XXX |
Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 18, 2025, Lumito's stock price is SEK 0 (or $0).
Lumito has current market cap of SEK 125M (or $13.0M), and EV of SEK 119M (or $12.4M).
See Lumito trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$12.4M | $13.0M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 18, 2025, Lumito has market cap of $13.0M and EV of $12.4M.
Lumito's trades at 1203.3x EV/Revenue multiple, and -4.6x EV/EBITDA.
Equity research analysts estimate Lumito's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Lumito's P/E ratio is not available.
See valuation multiples for Lumito and 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $13.0M | XXX | $13.0M | XXX | XXX | XXX |
EV (current) | $12.4M | XXX | $12.4M | XXX | XXX | XXX |
EV/Revenue | n/a | XXX | 1203.3x | XXX | XXX | XXX |
EV/EBITDA | n/a | XXX | -4.6x | XXX | XXX | XXX |
EV/EBIT | n/a | XXX | -3.1x | XXX | XXX | XXX |
EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
P/E | n/a | XXX | -3.0x | XXX | XXX | XXX |
EV/FCF | n/a | XXX | -3.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialLumito's revenue per employee in the last FY averaged $10K, while opex per employee averaged $4.4M for the same period.
Lumito's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Lumito's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Lumito and other 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
EBITDA Margin | n/a | XXX | -26127% | XXX | XXX | XXX |
EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $10K | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $4.4M | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 43077% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Australian Clinical Labs | XXX | XXX | XXX | XXX | XXX | XXX |
Clarity Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
Cyclopharm | XXX | XXX | XXX | XXX | XXX | XXX |
Healius | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Lumito acquired XXX companies to date.
Last acquisition by Lumito was XXXXXXXX, XXXXX XXXXX XXXXXX . Lumito acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was Lumito founded? | Lumito was founded in 2010. |
Where is Lumito headquartered? | Lumito is headquartered in Sweden. |
How many employees does Lumito have? | As of today, Lumito has 1 employees. |
Is Lumito publicy listed? | Yes, Lumito is a public company listed on NGM. |
What is the stock symbol of Lumito? | Lumito trades under LUMITO ticker. |
When did Lumito go public? | Lumito went public in 2018. |
Who are competitors of Lumito? | Similar companies to Lumito include e.g. Australian Clinical Labs, Clarity Pharmaceuticals, CurveBeam AI, Cyclopharm. |
What is the current market cap of Lumito? | Lumito's current market cap is $13.0M |
Is Lumito profitable? | Yes, Lumito is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.